Home
Physicians
Patients
Potential Partners
A Better Way to Measure Liver Function
Non-invasive tests made from natural compounds
Assesses the portal circulation
Estimates portal-systemic shunt
May detect disease in its earliest stages
ABOUT US
Dr. Everson Bio
News
RESEARCH
Research Publications
Potential Partner Info
Sponsored Trials
PRODUCTS & SERVICES
Physician Info
Patient Info
RESOURCES
Liver Disease FAQ
Glossary of Terms
Further Reading
Related Links
CONTACT US
FURTHER READING
Published Papers:
Below is a listing of selected recently published papers by Dr. Gregory T. Everson:
Portal-systemic Shunting in Patients with Fibrosis or Cirrhosis due to Chronic Hepatitis C: the Minimal Model for Measuring Cholate Clearances and Shunt.
The Spectrum of Hepatic Functional Impairment in Compensated Chronic Hepatitis C: Results from the HALT-C Trial.
Quantitative Tests of Liver Function Measure Hepatic Improvement after Sustained Virologic Response: Results from the HALT-C Trial.
Hepatic Impairment Measured by Quantitative Tests of Liver Function (QLFTs) Predicts Clinical Outcome in Patients with Advanced Fibrosis: Results from the HALT-C Trial.
Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy.
Books:
Below is a listing of books either written or contributed by Dr. Gregory T. Everson.
Living with Hepatitis B:
A Survivor’s Guide
Living with Hepatitis C:
A Survivor’s Guide
Living with Hemochromatosis: Expert Answers to Your Questions about Iron Overload
Liver Transplantation: Challenging Controversies and Topics
My Mom Has Hepatitis C
Did You Know?
Cirrhosis of the liver is the seventh leading cause of death in the United States(
NIDDK
).
Want more information?
Have Questions?
Contact HepQuant Now